Acetylcholinesterase Biosensor Based on Reduced Graphene Oxide – Carbon Black Composite for Determination of Reversible Inhibitors

Abstract

For the first time, acetylcholinesterase (AChE) biosensors based on mixed carbon nanomaterials (electrochemically reduced graphene oxide (ERGO) and carbon black (CB) particles) were described for the determination of antidementia drugs. Changes in the content of underlying layer allowed varying selectivity and sensitivity of the inhibitor determination. Appropriate limits of detection (LOD) varied in the range from 1 pM to 0.1 nM for donepezil, 5 nM–0.1 μM for berberine, 0.1–50 nM for huperzine A and 0.1–300 nM for galantamine. Variation in the inhibition measurement parameters can be used for increasing selectivity of the measurements.